|
Volumn 23, Issue 4 SUPPL. 9, 1996, Pages 28-32
|
Aromatase inhibitors in metastatic breast cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLUTETHIMIDE;
ANASTROZOLE;
ANTIESTROGEN;
AROMATASE INHIBITOR;
ATAMESTANE;
CYTOCHROME P450;
ESTROGEN;
EXEMESTANE;
FADROZOLE;
FORMESTANE;
KETOCONAZOLE;
LETROZOLE;
MEGESTROL;
PYRIDOGLUTETHIMIDE;
TAMOXIFEN;
TRILOSTANE;
VOROZOLE;
BREAST CANCER;
CANCER HORMONE THERAPY;
CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MECHANISM;
ENZYME INHIBITION;
ENZYME MECHANISM;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
META ANALYSIS;
METASTASIS;
PHASE 1 CLINICAL TRIAL;
POSTMENOPAUSE;
PRIORITY JOURNAL;
REVIEW;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
FADROZOLE;
FEMALE;
HUMANS;
MEGESTROL ACETATE;
NEOPLASM METASTASIS;
NEOPLASMS, HORMONE-DEPENDENT;
NITRILES;
TAMOXIFEN;
TRIAZOLES;
|
EID: 0029782953
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (21)
|
References (0)
|